Tirzepatide

Order Tirzepatide in 30 and 40 mg online at Invus Labs. See prices and stock status. For laboratory research only, not for human use.

40 mg · SEK 1,199

Out of stock

All peptides · Shipping and delivery

What is Tirzepatide?

Tirzepatide is a modified peptide containing 39 amino acids. Its structure and catalog quantity labels help distinguish molecular identity from a particular product pack.

Tirzepatide has a modified GIP-based peptide sequence with an attached fatty-acid moiety. Its scientific description therefore covers both the amino-acid chain and the chemical modification.

Tirzepatide is described as a dual agonist at GIP and GLP-1 receptors. This describes one molecule with two receptor targets, rather than two peptides mixed in a pack.

Product information

Product name: Tirzepatide
Substance type: Modified peptide
Peptide chain: 39 amino acids
Literature description: GIP and GLP-1 receptor agonist
Listed variants: 30 mg / 40 mg
Intended for: In-vitro research. Not for human or animal use.

Comparing Tirzepatide and Retatrutide

Retatrutide and Tirzepatide are distinct substances. Retatrutide is also described in relation to the glucagon receptor, whereas the dual-agonist description of Tirzepatide refers to GIP and GLP-1.

The stated mg quantity is a separate product characteristic. It does not specify a solution concentration or establish that different peptides are interchangeable in an assay.

Frequently asked questions about Tirzepatide

How many amino acids does Tirzepatide contain?

Its modified peptide chain contains 39 amino acids and has an attached fatty-acid moiety.

Does dual agonist mean Tirzepatide is a blend?

No. Dual agonist describes two receptor targets for the molecule. A blend contains multiple separately named components.

Which variants of Tirzepatide are listed?

Listed variants: 30 mg / 40 mg. The quantity belongs to each product variant; current availability is shown in the variant selector.